CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 10.29: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
4.10%
Annual Rate
CNY 0.26Paid unknown
Payout Ratio
126.7%High
Payback Period
23.8 yr
Last Ex-Dividend
Aug 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.67BCNY544.42M · vs all stocks (USD)
Trailing P/E
31.14xRevenue (TTM)
784.94MCNY116.41M · vs all stocks (USD)
Profit Margin
15.11%Beta
0.3100xvs all stocks
52-Week Change
-11.17%vs all stocks
Forward Annual Dividend Yield
4.10%vs all stocks
Market Capitalization
3.67BCNY544.42M · vs all stocks (USD)
Enterprise Value
3.39BCNY502.19M · vs all stocks (USD)
Trailing P/E
31.14xPrice to Sales (TTM)
4.81xPrice to Book (MRQ)
5.34xEnterprise to Revenue
4.31xEnterprise to EBITDA
21.34xGross Margin
77.69%Profit Margin
15.11%Operating Margin
20.95%Return on Assets (TTM)
8.04%Return on Equity (TTM)
16.20%Revenue (TTM)
784.94MCNY116.41M · vs all stocks (USD)
Revenue per Share (TTM)
1.39CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-16.00%Gross Profit (TTM)
605.21MCNY89.75M · vs all stocks (USD)
EBITDA (TTM)
138.67MCNY20.56M · vs all stocks (USD)
Net Income (TTM)
118.61MCNY17.59M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
41.70%Operating Cash Flow (TTM)
134.60MCNY19.96M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
94.62MCNY14.03M · vs all stocks (USD)
Forward Annual Dividend Rate
0.2600CNYUpdated Aug 19, 2026Forward Annual Dividend Yield
4.10%vs all stocks
Trailing Annual Dividend Rate
0.2630CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
4.10%vs all stocks
Payout Ratio
126.67%Minority Interest (Equity)
-2.92MCNYFY2025 · Dec 31, 2025Revenue
816.95MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
201.11MCNYFY2025 · Dec 31, 2025Gross Profit
615.84MCNYFY2025 · Dec 31, 2025Operating Income
96.73MCNY14.35M · vs all stocks (USD)
Pre-tax Income
102.38MCNYFY2025 · Dec 31, 2025Income Tax Expense
13.59MCNYFY2025 · Dec 31, 2025Net Income
88.79MCNYFY2025 · Dec 31, 2025EBIT
102.44MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
132.78MCNYFY2025 · Dec 31, 2025Research & Development
36.39MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
341.19MCNYFY2025 · Dec 31, 2025Other Operating Expenses
14.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.04MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
62.31KCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
88.79MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
6.92MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
104.08MCNYFY2025 · Dec 31, 2025Free Cash Flow
90.29MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
394.04MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
88.79MCNYFY2025 · Dec 31, 2025Other Non-cash Items
62.31KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
3.30MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
11.93MCNYFY2025 · Dec 31, 2025Capital Expenditures
13.79MCNYFY2025 · Dec 31, 2025Net Acquisitions
820.00KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
14.61MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-69.27MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.15MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-70.41MCNYFY2025 · Dec 31, 2025Shares Outstanding
577.21MSharesUpdated Aug 19, 2026Float Shares
277.56MSharesUpdated Aug 19, 2026% Held by Insiders
53.46%vs all stocks
% Held by Institutions
1.52%vs all stocks
Total Cash (MRQ)
386.42MCNY57.31M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6690CNYUpdated Aug 19, 2026Total Debt (MRQ)
788.77KCNY116.98K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0011xCurrent Ratio (MRQ)
2.36xBook Value per Share (MRQ)
1.23CNYUpdated Aug 19, 2026Total Assets
977.37MCNY144.94M · vs all stocks (USD)
Total Current Assets
566.77MCNYFY2025 · Dec 31, 2025Total Liabilities
256.47MCNYFY2025 · Dec 31, 2025Total Non-current Assets
410.60MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
15.74MCNYFY2025 · Dec 31, 2025Total Current Liabilities
240.73MCNYFY2025 · Dec 31, 2025Cash
394.04MCNYFY2025 · Dec 31, 2025Cash Equivalents
369.95KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
394.41MCNYFY2025 · Dec 31, 2025Accounts Receivable
67.13MCNYFY2025 · Dec 31, 2025Inventory
93.46MCNYFY2025 · Dec 31, 2025Accounts Payable
38.75MCNYFY2025 · Dec 31, 2025Short-term Debt
920.31KCNYFY2025 · Dec 31, 2025Other Current Liabilities
136.08MCNYFY2025 · Dec 31, 2025Long-term Debt
233.38KCNYFY2025 · Dec 31, 2025Common Stock (Book)
577.21MCNYFY2025 · Dec 31, 2025Retained Earnings
84.66MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
720.90MCNY106.91M · vs all stocks (USD)
52-Week Low
5.47CNYUpdated Aug 19, 202652-Week High
8.47CNYUpdated Aug 19, 202652-Week Change
-11.17%vs all stocks
Beta
0.3100xvs all stocks
50-Day MA
6.13CNYUpdated Aug 19, 2026200-Day MA
6.68CNYUpdated Aug 19, 2026Avg 10-Day Volume
11.95MSharesUpdated Aug 19, 2026Avg 30-Day Volume
15.22MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.2100CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.27Dividend per Share: 0.26Earnings per Share: 0.21
Financial Health
Altman Z-Score 10.29: safe zoneNotable
Altman Z-Score: 10.29
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Pulike Biological Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Sailun Biotech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
TaiMed Biologics Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
NeuroPace Inc.
Tier 1ProductionApproval-Gated PipelineRule
Morepen Laboratories Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Relmada Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Lifestrong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Bliss GVS Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hinova Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Nanjing Well Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Jumpcan Pharmaceutical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
CIE Automotive India Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Manhattan Associates Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities